SPOTLIGHT -
Legal: Shifting Perspective on Off-Label Promotion
The omission of criminal charges for off-label promotion of Serostim is surprising, because the government's earlier plea with Pfizer sent a strong signal that it would criminally charge companies engaged in off-label marketing.